Global Pediatric Vaccine Market Will Reach to USD 56.28 Billion By 2025: Zion Market Research

    NEXT STORY
    Ritter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory Board
    PREV STORY
    Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Curis to Present at the Jefferies Healthcare Conference

    LEXINGTON, Mass., June 02, 2016 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    ASTRAZENECA FURTHER SHARPENS FOCUS THROUGH AGREEMENT WITH GENZYME FOR RARE DISEASE MEDICINE CAPRELSA

    AstraZeneca today announced that it has entered into a definitive agreement with Genzyme to ...

    author_avatar
    NASDAQ Market News

    Independence Blue Cross announces new telemedicine coverage

    PHILADELPHIA, March 14, 2016 (GLOBE NEWSWIRE) -- Independence Blue Cross (Independence) announced that it ...

    author_avatar
    NASDAQ Market News